Li, C., Chen, T., Zhou, H., Feng, Y., Hoi, M. P. M., Ma, D., . . . Lee, S. M. Y. (2018). BHDPC Is a Novel Neuroprotectant That Provides Anti-neuroinflammatory and Neuroprotective Effects by Inactivating NF-κB and Activating PKA/CREB. Frontiers in Pharmacology, 9, . https://doi.org/10.3389/fphar.2018.00614
Chicago Style (17th ed.) CitationLi, Chuwen, Tongkai Chen, Hefeng Zhou, Yu Feng, Maggie P. M. Hoi, Dan Ma, Chao Zhao, Ying Zheng, and Simon M. Y. Lee. "BHDPC Is a Novel Neuroprotectant That Provides Anti-neuroinflammatory and Neuroprotective Effects by Inactivating NF-κB and Activating PKA/CREB." Frontiers in Pharmacology 9 (2018). https://doi.org/10.3389/fphar.2018.00614.
MLA (9th ed.) CitationLi, Chuwen, et al. "BHDPC Is a Novel Neuroprotectant That Provides Anti-neuroinflammatory and Neuroprotective Effects by Inactivating NF-κB and Activating PKA/CREB." Frontiers in Pharmacology, vol. 9, 2018, https://doi.org/10.3389/fphar.2018.00614.
